135 related articles for article (PubMed ID: 26606396)
1. Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient.
Newman KA; Ahlman MA; Hughes M; Malayeri AA; Pratt D; Grayson PC
Arthritis Rheumatol; 2016 May; 68(5):1135. PubMed ID: 26606396
[No Abstract] [Full Text] [Related]
2. Successful Treatment of Diffuse Large B-cell Lymphoma Involving Multiple Renal and Bone Infiltrations Presenting with Giant Cell Arteritis-like Manifestations.
Yokota K; Morimoto K; Yazawa H; Tsuzuki Wada T; Sakamoto T; Terui Y; Kaneko S; Inoue T; Okada H; Akiyama Y; Mimura T
Intern Med; 2024 Jun; 63(11):1645-1652. PubMed ID: 37952957
[TBL] [Abstract][Full Text] [Related]
3. DLBCL developed into fatal liver failure during rituximab-containing chemotherapy.
Shimazu Y; Nohgawa M
J Clin Exp Hematop; 2019; 59(2):93-95. PubMed ID: 31257349
[No Abstract] [Full Text] [Related]
4. BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
Palickova M; Mocikova H; Vernerova Z; Campr V; Kozak T
Leuk Lymphoma; 2013 Sep; 54(9):2081-2. PubMed ID: 23311295
[No Abstract] [Full Text] [Related]
5. Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass.
Öneç B; Öneç K; Esbah AÜ; Esbah O
Turk J Haematol; 2016 Dec; 33(4):362-363. PubMed ID: 27095140
[No Abstract] [Full Text] [Related]
6. Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma.
Cho H; Yoon DH; Kim JH; Ko YB; Kwon BS; Song IH; Suh C
Korean J Intern Med; 2016 May; 31(3):605-7. PubMed ID: 26968186
[No Abstract] [Full Text] [Related]
7. MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.
Lai C; Roschewski M; Melani C; Pittaluga S; Shovlin M; Steinberg SM; Dunleavy K; Pack S; Jaffe ES; Wilson WH
Leuk Lymphoma; 2018 Feb; 59(2):505-508. PubMed ID: 28641474
[No Abstract] [Full Text] [Related]
8. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
Castillo JJ; Reagan JL; Sikov WM; Winer ES
Br J Haematol; 2015 May; 169(3):352-5. PubMed ID: 25612847
[TBL] [Abstract][Full Text] [Related]
10. Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?
Mondello P; Cuzzocrea S; Pitini V; Aloisi C; Mian M
Acta Oncol; 2015 Jun; 54(6):953-5. PubMed ID: 25831143
[No Abstract] [Full Text] [Related]
11. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
[No Abstract] [Full Text] [Related]
12. Case records of the Massachusetts General Hospital. Case 26-2007 - a 61-year-old man with recurrent fevers.
Meyer GS; Hales CA; Amrein PC; Sharma A; Kradin RL
N Engl J Med; 2007 Aug; 357(8):807-16. PubMed ID: 17715414
[No Abstract] [Full Text] [Related]
13. Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma.
Sengupta S; Benkers T; Blitstein M; Palmer E; Plotkin SR; Abramson JS
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e111-3. PubMed ID: 24581553
[No Abstract] [Full Text] [Related]
14. Extreme exigency in the extremity: an illustrative case of diffuse large B-cell lymphoma occurring in the arm.
Abid MB; Wang S; Loi HY; Chan EHL; Poon LM; de Mel S
Singapore Med J; 2018 Jul; 59(7):397-398. PubMed ID: 30109350
[No Abstract] [Full Text] [Related]
15. Without Headache: Fever of Unknown Cause Due to Giant Cell Arteritis.
Martinelli N; Marcolini L
J Clin Rheumatol; 2018 Jan; 24(1):38-39. PubMed ID: 28661925
[No Abstract] [Full Text] [Related]
16. Utility of interim and end-of-treatment [(18)F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma.
Huntington SF; Nasta SD; Schuster SJ; Doshi JA; Svoboda J
Leuk Lymphoma; 2015; 56(9):2579-84. PubMed ID: 25629993
[TBL] [Abstract][Full Text] [Related]
17. Biopsy of the temporal artery in a patient with giant cell arteritis.
Toko M; Oiwa H; Mihara S; Sugiyama E
Intern Med; 2013; 52(18):2165. PubMed ID: 24042537
[No Abstract] [Full Text] [Related]
18. Diffuse large B-cell lymphoma resembling a metastatic liver tumour.
Saitoh Y; Gotoh M; Katagiri S; Ohyashiki K
Br J Haematol; 2015 Jan; 168(1):1. PubMed ID: 25312576
[No Abstract] [Full Text] [Related]
19. Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma.
Stewart DA; Kloiber R; Owen C; Bahlis NJ; Duggan P; Mansoor A; Bence-Bruckler I
Leuk Lymphoma; 2014 Sep; 55(9):2064-70. PubMed ID: 24188476
[TBL] [Abstract][Full Text] [Related]
20. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
